Clinical Trial Update: Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral cyclophosphamide versus doxorubicin in patients aged 65 and older with advanced or metastatic soft tissue sarcoma; currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: UNICANCER | Conditions: Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma | Phase 3 | Status: RECRUITING